Tumor denials in California external review

What the reviewers wrote

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for proton beam radiation therapy. The utilization of proton beam radiation therapy remains an area of debate. Proton beam has unique properties compared to standard photon or x-ray beam in its ability to deposit radiation dose. Oftentimes, fewer proton beams can be utilized to achieve a dose distribution similar to a photon beam. This potentially results in fewer areas of low scattered radiation dose when using proton beams. Proton beam is also beneficial in cases of re-irradiation when there is radiation exposure to adjacent tissues. Currently, the National Comprehensive Cancer Network (NCCN) guidelines state that proton therapy is utilized and strongly indicated in settings where severe toxicities would result if normal tissue constraints cannot be met by photon beam.

Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for proton beam radiation therapy (60 Gy in 30 fractions). The utilization of proton beams in treating pineal tumors is an area of active investigation. Proton beam has unique properties compared to standard photon or x-ray beam in its ability to deposit radiation doses. Often, fewer proton beams can be utilized to achieve a dose distribution similar to standard x-ray beams, potentially resulting in less radiation exposure to critical organs. Proton therapy is currently utilized and strongly indicated in settings where severe toxicities would result if normal tissue constraints cannot be met by standard x-ray beams.

Where the denial was upheld

Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for proton beam radiation therapy. Leptomeningeal cancer, also known as carcinomatous meningitis, is a rare and aggressive form of cancer that affects the brain and spinal cord. Standard management of patients with leptomeningeal cancer typically involves a multimodal approach that combines radiation therapy, chemotherapy, and supportive care. Radiation therapy is used to target the affected areas of the central nervous system and prevent the cancer from spreading further. Depending on the location and extent of the cancer, radiation therapy may involve whole-brain radiation, focal radiation, or a combination of both. This treatment can help to relieve symptoms such as headaches, seizures, and neurological deficits and may also improve overall survival.

Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for palliative treatment of the right lateral orbit with proton beam therapy (30 Gy delivered in 10-15 fractions). When treating patients with orbital metastases, the standard of care therapy is with photons. For most patients, intensity-modulated radiation therapy (IMRT) with photons is a highly effective and well-established treatment option for orbital metastases. IMRT offers precise control over the radiation beams, allowing for targeted and conformal radiation delivery to the tumor while minimizing exposure to adjacent healthy structures, such as the optic nerve and eye. The advantages of IMRT include its accessibility, established safety profile, and the ability to deliver high doses of radiation to achieve tumor control.

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving tumor, then check the rights and deadlines that apply to your plan.